The new ability to purchase the birth-control pill over the counter marks a significant milestone in reproductive health, expanding access and convenience for users.
The effort to bring Opill to market reflects over 20 years of advocacy by reproductive-justice groups, culminating in its FDA approval and OTC availability.
Studies showed that individuals could understand package warnings about potential health risks, which is crucial for safe use of over-the-counter contraceptives.
Free the Pill focused on ensuring the first OTC pill would be progestin-only, an important decision that reflects priorities in reproductive health care.
Collection
[
|
...
]